Prevalence of risk phenotypes associated with <i>CYP2C9*2, *3,</i> and <i>VKORC1 c.-1639G>A</i> genetic polymorphisms in world populations: implications in clinical practice. [PDF]
Front PharmacolBiswas M +6 more
europepmc +1 more source
Electro-encephalographic surrogate measures fail to describe the pharmacodynamic interaction between ketamine and propofol. [PDF]
, 2004 Mortier, Eric +2 more
core +1 more source
PP148—Influence of CYP2C9 IVS8-109A>T Polymorphism on Losartan Oxidation in Healthy Ecuadorians [PDF]
, 2013 Pedro Dorado +5 more
openalex +1 more source
The Activation of Cytochrome P450 2C9 Is Facilitated by the Coenzyme Forms of Vitamin B2. [PDF]
MoleculesKoroleva PI +5 more
europepmc +1 more source
Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. [PDF]
Genes (Basel)Kalak M +3 more
europepmc +1 more source
Identification and validation of icaritin-associated prognostic genes in hepatocellular carcinoma through network pharmacology, bioinformatics analysis, and cellular experiments. [PDF]
Front ImmunolShi Y +7 more
europepmc +1 more source
The allele frequency of CYP2C9 and VKORC1 in the Southern Khorasan population
, 2017 Mohsen Naseri +3 more
openalex +1 more source
Herb-drug interaction of Astragali Radix based on in vitro incubation and pharmacokinetic assessment. [PDF]
BMC Complement Med TherWang T +6 more
europepmc +1 more source